Our Research Areas
The Brain Tumor Genetics Lab explores genetic components of a variety of primary central nervous system neoplasms and their impact on patient outcomes. We are interested in using our knowledge of genetic changes to better diagnose and treat these diseases.
Our lab is currently studying ways to personalize brain tumor treatments and identify factors that affect responses to therapy. We accomplish this by evaluating our current results and outcomes in the operating room and clinic, and also by discovering the underlying mechanisms of brain and spinal cord tumors and how those can be targeted with new therapeutic agents.
Areas of Investigation
Brain and Spinal Cord Tumor Genetics
CNS Tumor Outcomes and Quality of Care
Trigeminal Neuralgia Surgical Strategies
Brain and Spinal Cord Tumor Biomarkers
Neuronal Injury Biomarkers
Neurotrauma Outcomes
Publications
-
Genomic discoveries in adult astrocytoma
Wang J, Bettegowda C. Curr Opin Genet Dev. 2015 Feb;30:17-24. doi: 10.1016/j.gde.2014.12.002. Epub 2015 Jan 20. PMID: 25616158; PMCID: PMC4859210.Genetics and immunotherapy: using the genetic landscape of gliomas to inform management strategies
Wang JY, Bettegowda C. J Neurooncol. 2015 Jul;123(3):373-83. doi: 10.1007/s11060-015-1730-4. Epub 2015 Feb 21. PMID: 25697584.Genomic Landscape of Intramedullary Spinal Cord Gliomas
Zhang M, Iyer RR, Azad TD, Wang Q, Garzon-Muvdi T, Wang J, Liu A, Burger P, Eberhart C, Rodriguez FJ, Sciubba DM, Wolinsky JP, Gokaslan Z, Groves ML, Jallo GI, Bettegowda C.Sci Rep. 2019 Dec 10;9(1):18722. doi: 10.1038/s41598-019-54286-9.PMID: 31822682 -
Beyond guidelines: analysis of current practice patterns of AANS/CNS tumor neurosurgeons
Bander ED, Sherman JH, Bettegowda C, Aghi MK, Sheehan J, Ramakrishna R.J Neurooncol. 2021 Feb;151(3):361-366. doi: 10.1007/s11060-020-03389-9. Epub 2021 Feb 21.PMID: 33611703 Review.Health related quality of life outcomes following surgery and/or radiation for patients with potentially unstable spinal metastases
Versteeg AL, Sahgal A, Rhines LD, Sciubba DM, Schuster JM, Weber MH, Lazary A, Boriani S, Bettegowda C, Fehlings MG, Clarke MJ, Arnold PM, Gokaslan ZL, Fisher CG; AOSpine Knowledge Forum Tumor.Spine J. 2021 Mar;21(3):492-499. doi: 10.1016/j.spinee.2020.10.017. Epub 2020 Oct 22.PMID: 33098985Molecular foundations of primary spinal tumors-implications for surgical management
Azad TD, Jiang B, Bettegowda C.Ann Transl Med. 2019 May;7(10):222. doi: 10.21037/atm.2019.04.46.PMID: 31297387Assessing the Effectiveness of Systemic Therapy after Stereotactic Radiosurgery on Cancer Recurrence and All-Cause Mortality
Al-Khindi T, Shen CJ, Peng L, Redmond KJ, Lim M, Kleinberg LR, Bettegowda C.World Neurosurg. 2019 Sep;129:e572-e581. doi: 10.1016/j.wneu.2019.05.218. Epub 2019 May 31.PMID: 31158536 -
Percutaneous Procedures for the Treatment of Trigeminal Neuralgia
Wang JY, Bender MT, Bettegowda Ch. Neurosurg Clin N Am. 2016 Jul;27(3):277-95. doi: 10.1016/j.nec.2016.02.005. PMID: 27324995.Association Between Radiofrequency Rhizotomy Parameters and Duration of Pain Relief in Trigeminal Neuralgia Patients with Recurrent Pain
Xie E, Garzon-Muvdi T, Bender M, Doshi T, Carson B, Lim M, Bettegowda C.World Neurosurg. 2019 Sep;129:e128-e133. doi: 10.1016/j.wneu.2019.05.059. Epub 2019 May 15.PMID: 31102773 -
Spinal column chordoma: prognostic significance of clinical variables and T (brachyury) gene SNP rs2305089 for local recurrence and overall survival
Bettegowda C, Yip S, Lo SL, Fisher CG, Boriani S, Rhines LD, Wang JY, Lazary A, Gambarotti M, Wang WL, Luzzati A, Dekutoski MB, Bilsky MH, Chou D, Fehlings MG, McCarthy EF, Quraishi NA, Reynolds JJ, Sciubba DM, Williams RP, Wolinsky JP, Zadnik PL, Zhang M, Germscheid NM, Kalampoki V, Varga PP, Gokaslan ZL; AOSpine Knowledge Forum Tumor. Neuro Oncol. 2017 Mar 1;19(3):405-413. doi: 10.1093/neuonc/now156. PMID: 27663388; PMCID: PMC5464366.Applications of DNA-Based Liquid Biopsy for Central Nervous System Neoplasms
Wang J, Bettegowda C. J Mol Diagn. 2017 Jan;19(1):24-34. doi: 10.1016/j.jmoldx.2016.08.007. Epub 2016 Nov 15. PMID: 27863260.Liquid biopsy in gliomas: a RANO review and proposals for clinical applications
Soffietti R, Bettegowda C, Mellinghoff IK, Warren KE, Ahluwalia MS, De Groot JF, Galanis E, Gilbert MR, Jaeckle KA, Le Rhun E, Rudà R, Seoane J, Thon N, Umemura Y, Weller M, van den Bent MJ, Vogelbaum MA, Chang SM, Wen PY.Neuro Oncol. 2022 Jan 6:noac004. doi: 10.1093/neuonc/noac004. Online ahead of print.PMID: 34999836Genotype-Phenotype Correlations in Neurofibromatosis and Their Potential Clinical Use
Bettegowda C, Upadhayaya M, Evans DG, Kim A, Mathios D, Hanemann CO; REiNS International Collaboration.Neurology. 2021 Aug 17;97(7 Suppl 1):S91-S98. doi: 10.1212/WNL.0000000000012436. Epub 2021 Jul 6.PMID: 34230207Biomarkers and focused ultrasound: the future of liquid biopsy for brain tumor patients
Rincon-Torroella J, Khela H, Bettegowda A, Bettegowda C.J Neurooncol. 2021 Oct 6. doi: 10.1007/s11060-021-03837-0. Online ahead of print.PMID: 34613580 Review.The mutational landscape of spinal chordomas and their sensitive detection using circulating tumor DNA
Mattox AK, Yang B, Douville C, Lo SF, Sciubba D, Wolinsky JP, Gokaslan ZL, Robison J, Blair C, Jiao Y, Bettegowda C.Neurooncol Adv. 2020 Dec 8;3(1):vdaa173. doi: 10.1093/noajnl/vdaa173. eCollection 2021 Jan-Dec.PMID: 33543146TERT Promoter Mutation Analysis for Blood-Based Diagnosis and Monitoring of Gliomas
Muralidharan K, Yekula A, Small JL, Rosh ZS, Kang KM, Wang L, Lau S, Zhang H, Lee H, Bettegowda C, Chicoine MR, Kalkanis SN, Shankar GM, Nahed BV, Curry WT, Jones PS, Cahill DP, Balaj L, Carter BS.Clin Cancer Res. 2021 Jan 1;27(1):169-178. doi: 10.1158/1078-0432.CCR-20-3083. Epub 2020 Oct 13.PMID: 33051308Liquid biopsy for pediatric diffuse midline glioma: a review of circulating tumor DNA and cerebrospinal fluid tumor DNA
Azad TD, Jin MC, Bernhardt LJ, Bettegowda C.Neurosurg Focus. 2020 Jan 1;48(1):E9. doi: 10.3171/2019.9.FOCUS19699.PMID: 31896079The potential of cerebrospinal fluid-based liquid biopsy approaches in CNS tumors
Mattox AK, Yan H, Bettegowda C.Neuro Oncol. 2019 Dec 17;21(12):1509-1518. doi: 10.1093/neuonc/noz156.PMID: 31595305Prognostic significance of human telomerase reverse transcriptase promoter region mutations C228T and C250T for overall survival in spinal chordomas.
Bettegowda C, Yip S, Jiang B, Wang WL, Clarke MJ, Lazary A, Gambarotti M, Zhang M, Sciubba DM, Wolinsky JP, Goodwin CR, McCarthy E, Germscheid NM, Sahgal A, Gokaslan ZL, Boriani S, Varga PP, Fisher CG, Rhines LD. Neuro Oncol. 2019 Aug 5;21(8):1005-1015